INVESTORS
Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company
dedicated to elevating treatment experiences and outcomes for patients.
VIRTUAL KOL EVENT HELD AUGUST 10, 2023
Discussion on Phase 3 Study of Rivoceranib in Combination with Camrelizumab in Unresectable Hepatocellular Carcinoma (uHCC)
Stay Informed on Elevar – follow us on LinkedIn and X.